Clinical trials: Mild Cognitivie Impairment (MCI)
Alzheimer's Disease (AD), Dementia
δ in Dementia Clinical Trials
The goal of this clinical trial is to demonstrate potential improvements in clinical trial methods relating to dementia and cognitive decline.
- Conditions
- Alzheimer's Disease (AD), Dementia, Cognitive Decline, Mild Cognitivie Impairment (MCI)
- Trial name
- δND (NCT05592678)
- Testing
- Donepezil
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- The University of Texas Health Science Center at San Antonio